▲ Peaking
Health
Chronic type II interferon promotes tumor growth through mitochondrial RNA–induced type I interferon and prostaglandin synthesis
Chronic type II interferon promotes tumor growth
Immunology
20 independently detected trends connected to this subject, with the latest coverage first.
What Archynetys tracks about Immunology
This hub groups 20 separate news trends connected to Immunology, spanning June 22, 2026 through September 11, 2026. Each event page combines source coverage, attention velocity and a time-stamped explanation instead of treating every headline as a separate story.
The record below represents 153 article observations and 143 source signals, led by Health, Business, Science coverage. Use it to compare how individual events emerged, spread and changed over time.
◼ Archived
Health
🔮 fades ✓
Blocking a Single Immune Signal Made Old Mice Act Young Again
Blocking a single immune signal made aged mice behave like the young, upending assumptions about immune‑driven aging
◼ Archived
Health
🔮 fades ✓
Scientists Say a Key Trigger for Alzheimer’s Damage Isn’t Even in the Brain
8 news sources are covering this Health story right now — Archynetys is tracking how fast it spreads.
◼ Archived
Health
🔮 fades ✓
Could bats be an ally in the fight against cancer? New study uncovers secrets of their unique genetics
Bats wield a unique, cell‑killing immune system that could rewrite cancer treatment
◼ Archived
Health
🔮 fades ✓
North Carolina teen critically injured by rare brain-eating amoeba
19 news sources are covering this Health story right now — Archynetys is tracking how fast it spreads.
◼ Archived
Health
Scientists Discover a New Organ Hiding in The Skull
Medical researchers have identified previously unknown immune structures within the human skull, potentially reshaping brain cancer treatment.
◼ Archived
Health
🔮 fades ✓
How do people live beyond 110? Abundance of cancer-killing cells might be key
Researchers identify an abundance of specific, cancer-killing immune cells as a potential biological factor in human longevity past age 110.
◼ Archived
Health
🔮 fades ✓
Feel the burn: 90% of people heal faster by focusing on their pain
New research reveals that 90% of individuals may accelerate their healing process by intentionally focusing on acute pain sensations.
◼ Archived
Health
🔮 fades ✓
Chemovaccination with a late-liver-stage antimalarial induces durable immunity against malaria
Six outlets report a new malaria vaccine that uses mosquito bites to induce immunity.
◼ Archived
Business
🔮 fades ✓
Deerfield-backed Boulevard Bio embarks on ‘beautiful path to a cure’ with trio of immunology drugs
Boulevard Bio debuts with $65 million in funding to advance a pipeline of targeted antibody therapies focused on autoimmune disease.
◼ Archived
Science
Scientists have found a cell that fights infection by detonating. It bursts, kills everything within reach, and five minutes later there is nothing left to show it was ever there
Scientists have discovered a unique immune cell that sacrifices itself to fight infections.
◼ Archived
Health
🔮 fades ✓
High glucose thickens cancer cells' sugar shield, helping them evade immune attack
Research identifies high glucose levels as a factor in the thickening of cancer cells' sugar shields, potentially masking them from the immune system.
◼ Archived
Health
Do Altered Immune Cells Drive Skin Cancer in Immunosuppressed Patients?
New research suggests that altered immune cells may be driving skin cancer in immunosuppressed patients.
◼ Archived
Health
Inflammation Keeps Us Alive. It's Also Making Us Sick.
4 news sources are covering this Health story right now — Archynetys is tracking how fast it spreads.
◼ Archived
Business
🔮 holds ✗
Argenx to Buy Forte Biosciences for $2.2 Billion
8 news sources are covering this Business story right now — Archynetys is tracking how fast it spreads.
◼ Archived
Health
🔮 fades ✓
Breakdown of immune cells' interaction is key driver in aging, study finds
New research identifies the breakdown of immune cell communication as a primary driver of systemic aging.
◼ Archived
Health
🔮 fades ✓
Biologists pinpoint how common virus triggers multiple sclerosis
New biological research identifies specific Epstein-Barr virus components linked to the development of multiple sclerosis.
◼ Archived
Health
🔮 fades ✓
The First AI‑Designed Vaccine Has Been Tested in People. Here’s What Happened.
Clinical trials for the world's first AI-designed vaccine have entered human testing, marking a potential shift in medical development methodology.
◼ Archived
Health
🔮 fades ✓
Prime-and-pull vaccine may offer lasting genital herpes protection
A novel vaccine approach may soon offer long-term protection against genital herpes
◼ Archived
Business
🔮 fades ✓
AbbVie to Acquire Apogee Therapeutics, Deepening Immunology Portfolio
AbbVie is expanding its immunology portfolio through a nearly $11 billion acquisition of Apogee Therapeutics.